• Cisapride (R 51619): Nonselective 5-HT4 Agonist & hERG In...

  2026-03-24

  Cisapride is a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, serving as a standard tool in cardiac electrophysiology and serotonergic signaling research. Its well-characterized solubility and quality control parameters support reproducibility in high-content screening models. Use of Cisapride enables reliable benchmarking for cardiotoxicity and drug safety assays.

• Isradipine: Dihydropyridine Calcium Channel Blocker for R...

  2026-03-24

  Isradipine (Dynacirc) from APExBIO is a highly selective dihydropyridine calcium channel blocker, empowering researchers to dissect L-type calcium signaling in hypertension and neurodegenerative disease models. Its exceptional solubility, proven purity, and robust neuroprotective profile make it the go-to compound for advanced cardiovascular, neuroprotection, and pharmacology research workflows.

• Otilonium Bromide: Precision Antimuscarinic Agent for Neu...

  2026-03-23

  Otilonium Bromide stands out as a high-purity, robustly soluble acetylcholine receptor inhibitor, enabling reproducible cholinergic signaling studies in neuroscience and smooth muscle pharmacology. This article provides actionable protocols, troubleshooting strategies, and advanced applications, positioning APExBIO’s Otilonium Bromide as the go-to research compound for mechanistic and translational discovery.

• 2-APB (2-aminoethoxydiphenyl borate): IP3R Antagonist for...

  2026-03-23

  2-APB is a cell-permeable IP3 receptor antagonist and calcium mobilization inhibitor. It is widely used to dissect intracellular calcium signaling and apoptosis pathways in research settings. This article details its mechanism, benchmarks, and experimental limitations.

• Amiloride (MK-870): Redefining Sodium Channel and Endocyt...

  2026-03-22

  Explore how Amiloride (MK-870) from APExBIO is catalyzing the next wave of discovery in sodium channel research, epithelial physiology, and cellular endocytosis. This thought-leadership article blends mechanistic insights, evidence-based validation, and strategic guidance for translational researchers, extending well beyond standard product pages and integrating the latest peer-reviewed findings.

• Amikacin (BAY416651): Unlocking Aminoglycoside Advantages...

  2026-03-21

  Amikacin (BAY416651) stands out as a semi-synthetic aminoglycoside antibiotic with unique resistance to many modifying enzymes, making it an indispensable tool in antibiotic resistance research. This article delivers practical protocols, troubleshooting strategies, and advanced insights for leveraging Amikacin in studies of multidrug-resistant Enterobacter cloacae and Klebsiella pneumoniae, with a focus on experimental rigor and translational relevance.

• Gap26 Connexin 43 Mimetic Peptide: Unraveling Astrocyte G...

  2026-03-20

  Explore how Gap26, a connexin 43 mimetic peptide, uniquely advances neuroprotection and pain research through selective gap junction blockade. Discover its distinct role in astrocyte-mediated signaling and novel insights for neurodegenerative disease models.

• Phenytoin as a Precision Tool for Sodium Channel Modulati...

  2026-03-20

  Explore how phenytoin, an inactive voltage-gated sodium channel stabilizer, advances sodium channel modulation research and electrophysiology assays. This article delves into its mechanistic insights, experimental applications, and cutting-edge relevance to neurological disease models.

• Metoprolol Tartrate in Cardiovascular Research: β1-Select...

  2026-03-19

  Explore the advanced scientific applications of Metoprolol Tartrate, a cardioselective β1-adrenergic blocking agent, in cardiovascular and hematopoietic research. Uncover its unique mechanistic advantages, latest findings, and best practices for in vitro assays.

• Verapamil HCl (SKU B1867): Reliable Solutions for Cell-Ba...

  2026-03-19

  This article provides practical, scenario-driven guidance for biomedical researchers and lab technicians seeking reproducible results in cell viability, apoptosis, and inflammation assays. Using Verapamil HCl (SKU B1867), we address common pitfalls in calcium channel modulation, protocol optimization, and product selection, citing peer-reviewed evidence and linking to validated resources. Designed for scientists navigating experimental challenges, this piece highlights how APExBIO's Verapamil HCl advances workflow reliability and data quality.

• Otilonium Bromide: Mechanistic Insights and Emerging Tool...

  2026-03-18

  Explore the advanced antimuscarinic pharmacology of Otilonium Bromide as an acetylcholine receptor inhibitor for neuroscience research. This in-depth analysis uniquely reveals its mechanistic applications in receptor modulation and experimental design, offering perspectives not found in standard protocol guides.

• Gap26 Connexin 43 Mimetic Peptide: Precision in Gap Junct...

  2026-03-18

  Gap26, a selective connexin 43 mimetic peptide, empowers researchers to dissect intercellular communication with unmatched specificity, enabling advances in calcium signaling, ATP release inhibition, and neuroprotection research. Its robust performance across vascular, neuronal, and disease model systems positions it as the benchmark gap junction blocker peptide for translational and mechanistic studies.

• Lamotrigine: Sodium Channel Blocker for Epilepsy & Cardia...

  2026-03-17

  Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, is engineered for robust epilepsy and cardiac sodium current research. APExBIO's formulation ensures reproducibility and workflow flexibility, uniquely positioning Lamotrigine for cutting-edge CNS and neurocardiac studies.

• Lamotrigine (SKU B2249): Empowering Reliable CNS and Card...

  2026-03-17

  This article addresses real-world laboratory challenges in cell viability and CNS research, demonstrating how Lamotrigine (SKU B2249) delivers reproducibility, high purity, and workflow compatibility for mechanistic sodium channel and 5-HT pathway studies. Scenario-driven Q&As provide actionable guidance grounded in evidence and APExBIO's robust product data, equipping researchers with best practices for in vitro and translational research.

• DIDS: Mechanistic Insights and Emerging Frontiers in Chlo...

  2026-03-16

  Explore the advanced mechanisms and novel applications of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid), a leading anion transport inhibitor. This article delivers an in-depth perspective on chloride channel modulation and its impact on cancer, neuroprotection, and vascular research, exceeding standard assay-focused content.

11331 records 1/756 page Next 12345 下5页 Last page